Flucelvax® Quadrivalent 2026–2027 Flu Vaccine 60 mcg / 0.5 mL use for People 6 months+ Prefilled Syringe 0.5 mL

• Flucelvax Seqirus is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
• FLUCELVAX is approved for use in persons 6 Months of age and older
• FLUCELVAX QUADRIVALENT 0.5 mL pre-filled syringes contain no preservative or antibiotics
• FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2026–2027 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains:
• A/Idaho/07/2018 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Indiana/08/2018 (an A/Kansas/14/2017 (H3N2)-like virus), B/Iowa/06/2017 (a B/Colorado/06/2017-like virus), B/Singapore/INFTT-16-0610/2016 (a B/Phuket/3073/2013-like virus)

This Is A Cold Product!!!

Manufacturer # 70461032203
NDC # 70461032203
Product Insert Sheet
Similar Products